AUCKLAND, New Zealand, Oct. 14, 2016 /PRNewswire/ -- Fisher & Paykel Healthcare (NZX: FPH, ASX: FPH) today welcomed new research on the benefits of its Optiflow™ nasal high flow therapy. This research ...
Fisher & Paykel Healthcare has lifted its full-year profit 10 per cent to a record $NZ209.02m. (AAP) Fisher & Paykel's respiratory and home care products have helped ...
The dual-listed (FPH) health equipment provider lifted revenue 9.0 per cent to $NZ1.07 billion for the 12 months to March 31 as sales across its hospital group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback